Game-Changing Updates in the Management of Sickle Cell Disease
In this presentation, the speakers and panelists discuss sickle cell disease, its prevalence, new gene therapy management strategies, and relevant ethical considerations. A pioneering CRISPR patient gives her perspective on undergoing gene-editing therapy and how that has impacted her health and quality of life.
This Common Spirit Health Clinical Grand Rounds session took place on April 5, 2024 at 9:00 a.m. and has been approved for CME and Ethics credit.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
Physicians and advanced practice providers in family medicine, internal medicine, pediatrics, and other medical specialties need to receive regular updates on clinical best practices. Newly published, clinically relevant, evidence-based, peer-reviewed research articles will be used as an impetus for discussion. The series aims is to accelerate the practice of evidence-based medicine across the physician enterprise to expand clinical knowledge, enhance the quality of care, and improve patient outcomes. The series also aims to disseminate disease-specific clinical best practices and to encourage networking and collaboration within and across medical specialties.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Identify and discuss historical management of sickle cell disease and present the current state of treatment.
- Integrate strategies and best practices for implementing new therapies.
- Discuss the social and ethical issues that arise when weighing the cost and current availability of treatment against the proven benefit of treatment.
- Recognize the importance of reviewing and discussing new clinical evidence in the context of improving care delivery and patient outcomes.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Other Health Professionals
Specialties
- Family and Community Medicine
- Hematology
- Internal Medicine
- Pediatrics
Interest Groups
- Ethics
- Hospital Medicine
- Primary Care
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Panel Discussion
Accreditation/Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and CommonSpirit Health. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
Activity Director
Panelist
-
Nana E. Coleman, M.D., M.Ed.
System Senior Vice President of Academic Affairs, Associate Professor of Pediatrics
CommonSpirit Health, Baylor College of Medicine
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Term of Approval
April 1, 2024 through April 30, 2024. Original release date: April 1, 2024.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Kevin T. FitzGerald, S.J., Ph.D., Ph.D.
Chair and Associate Professor, Department of Medical Humanities
Creighton University (Omaha, Nebraska)
Disclosure:
Nothing to disclose.
Activity Director
-
Gary Greensweig, D.O.
Chief Physician Executive
CommonSpirit Health
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Brooke Burgess
System Director, Communications Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Gary Greensweig, D.O.
Chief Physician Executive
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
John Kniesche, M.P.H.
System Director, Clinical Support Services, Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Rachel Lytle, R.N., M.S.N., C.P.H.Q.
System Director for Clinical Standards and Variation Reduction
CommonSpirit Health Physician Enterprise
Disclosure:
Nothing to disclose.
-
Thomas McGinn, M.D., M.P.H.
Executive Vice President Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Disclosure:
Nothing to disclose.
Panelist
-
Nana E. Coleman, M.D., M.Ed.
System Senior Vice President of Academic Affairs, Associate Professor of Pediatrics
CommonSpirit Health, Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Gary Greensweig, D.O.
Chief Physician Executive
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Thomas McGinn, M.D., M.P.H.
Executive Vice President Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Disclosure:
Nothing to disclose.